Could long-acting medications facilitate "ending aids by 2030" in southern africa? An allocative efficiency analysis

Ended Project Grant Awarded Last action

Award ID
R01AA027481
Recipient
Awarding agency
Obligated
$6,344,162

Award facts

Assistance listing
93.273 Alcohol Research Programs
Completion date
Originally
Funding
  • $5,641,507.00 Federal
  • $702,655.00 Non-federal
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $666,898 $0
Amendment $666,898 $0
Amendment $682,242 $0
Amendment $682,242 $0
Amendment $702,655 $0
Amendment $702,655 $702,655
Amendment $0 $0
Amendment $0 $0
Amendment $724,289 $0
Original award $813,628 $0
Show all 12

Subawards

Subrecipient Amount Awarded
The Trustees Of Columbia University In The City Of New York Could long-acting medications facilitate “ending AIDS by 2030� in southern Africa? An allocative efficiency analysis - Resubmission - 1 $206,414
TBD Acquisition II, LLC Could long-acting medications facilitate “ending AIDS by 2030� in southern Africa? An allocative efficiency analysis - Resubmission - 1 $25,275

Quick answers

Who received award R01AA027481?

R01AA027481 was awarded to New York University by National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health) on September 25, 2019.

How much is award R01AA027481 worth?

$6,344,162 has been obligated on R01AA027481: $5,641,507 in federal funding and $702,655 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award